Rigorously tested and continuously validated in practice, Cytel software is used at thousands of pharmaceutical, biotech, medical device companies, and leading independent research institutes.
Cytel’s cutting-edge trial design and implementation expertise, with a specialty in adaptive trials, is helping sponsor companies of all sizes to increase success rates in clinical development.
DIA/Cytel Webinar Nov-20: Clinical Trials Reinvented - Register Free
Laurie Halloran and Cytel’s Irving Dark reveal the innovative product development advancements now helping clinical trial sponsors transform their trial strategies and practices.
CMO Summit West, San Francisco, November 3rd and 4th
Our workshop Nov 4th with Bay Area Onyx Pharmaceuticals for CMOs, CSOs, and fellow stakeholders on using adaptive designs and trial simulations to mitigate oncology development risk.
Innovative Methods in Clinical Trial Design, Triangle Park, NC, Nov 14th
Attend this one day seminar is dedicated and learn to design both early stage and confirmatory adaptive trials. Cytel experts Zoran Antonijevic and Charles Liu lead the interactive instruction.
What Clients Say
Simona Skerjanec, VP Medical Science
The Medicines Company
Steven B. Ketchum, VP Research and Development
Joe Heyes, VP
Early Stage Biostatistics Merck
Dr. Scott Harris, CMO
Dr. Patrice Rioux, VP, CMO
Sylvain Nicolas, Global Head Biostatistics Phase 1 Studies